These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 34187458)

  • 1. Healthcare provider and pregnant women's perspectives on the implementation of intermittent screening and treatment with dihydroartemisinin-piperaquine for malaria in pregnancy in western Kenya: a qualitative study.
    Hoyt J; Hill J; Achieng F; Ouma P; Kariuki S; Desai M; Webster J
    Malar J; 2021 Jun; 20(1):291. PubMed ID: 34187458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.
    Hill J; Ouma P; Oluoch S; Bruce J; Kariuki S; Desai M; Webster J
    Malar J; 2020 Nov; 19(1):433. PubMed ID: 33238999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya.
    Hill J; Hoyt J; Achieng F; Ouma P; L'lanziva A; Kariuki S; Desai M; Webster J
    PLoS One; 2016; 11(3):e0150259. PubMed ID: 26986471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
    Madanitsa M; Kalilani L; Mwapasa V; van Eijk AM; Khairallah C; Ali D; Pace C; Smedley J; Thwai KL; Levitt B; Wang D; Kang'ombe A; Faragher B; Taylor SM; Meshnick S; Ter Kuile FO
    PLoS Med; 2016 Sep; 13(9):e1002124. PubMed ID: 27622558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent screening and treatment or intermittent preventive treatment compared to current policy of single screening and treatment for the prevention of malaria in pregnancy in Eastern Indonesia: acceptability among health providers and pregnant women.
    Hoyt J; Landuwulang CUR; Ansariadi ; Ahmed R; Burdam FH; Bonsapia I; Poespoprodjo JR; Syafruddin D; Ter Kuile FO; Webster J; Hill J
    Malar J; 2018 Sep; 17(1):341. PubMed ID: 30261877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi.
    Almond D; Madanitsa M; Mwapasa V; Kalilani-Phiri L; Webster J; Ter Kuile F; Paintain L
    Malar J; 2016 Nov; 15(1):574. PubMed ID: 27894353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery effectiveness of and adherence to intermittent preventive treatment for malaria in pregnancy with dihydroartemisinin-piperaquine with or without targeted information transfer or sulfadoxine-pyrimethamine in western Kenya: a three-armed, pragmatic, open-label, cluster-randomised trial.
    Barsosio HC; Webster J; Omiti F; K'Oloo A; Odero IA; Ojuok MA; Odiwa D; Omondi B; Okello E; Dodd J; Taegtmeyer M; Kuile FOT; Lesosky M; Kariuki S; Hill J
    Lancet Glob Health; 2024 Oct; 12(10):e1660-e1672. PubMed ID: 39304238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data.
    Fernandes S; Were V; Gutman J; Dorsey G; Kakuru A; Desai M; Kariuki S; Kamya MR; Ter Kuile FO; Hanson K
    Lancet Glob Health; 2020 Dec; 8(12):e1512-e1523. PubMed ID: 33137287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
    Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
    Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of intermittent presumptive treatment with sulfadoxine-pyrimethamine using rapid diagnostic test screening and treatment with dihydroartemisinin-piperaquine at the first antenatal care visit (IPTp-SP+): study protocol for a randomized controlled trial.
    Kabuya JB; Ippolito MM; Sikalima J; Tende C; Champo D; Mwakazanga D; Young AMP; Mulenga M; Chongwe G; Manyando C
    Trials; 2021 Nov; 22(1):820. PubMed ID: 34801059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
    Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B
    PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provision and uptake of routine antenatal services: a qualitative evidence synthesis.
    Downe S; Finlayson K; Tunçalp Ö; Gülmezoglu AM
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012392. PubMed ID: 31194903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
    Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
    BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania.
    Mubyazi G; Bloch P; Kamugisha M; Kitua A; Ijumba J
    Malar J; 2005 Jul; 4():31. PubMed ID: 16033639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
    Yaya S; Kota K; Buh A; Bishwajit G
    BMC Public Health; 2019 Nov; 19(1):1467. PubMed ID: 31694607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of health care providers on the provision of intermittent preventive treatment in pregnancy in health facilities in Malawi.
    Yoder PS; Nsabagasani X; Eckert E; Moran A; Yé Y
    BMC Health Serv Res; 2015 Aug; 15():354. PubMed ID: 26318623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.
    González R; Nhampossa T; Mombo-Ngoma G; Mischlinger J; Esen M; Tchouatieu AM; Mendes A; Figueroa-Romero A; Zoleko-Manego R; Lell B; Lagler H; Stoeger L; Dimessa LB; El Gaaloul M; Sanz S; Méndez S; Piqueras M; Sevene E; Ramharter M; Saúte F; Menendez C;
    Lancet Infect Dis; 2024 May; 24(5):476-487. PubMed ID: 38224706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
    Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
    Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.